资讯

The 10-Year Health Plan marks a significant step forward in building an NHS that is faster, fairer and fit for the future. At NICE, we’re ready to deliver - using our expanded remit to accelerate ...
08 July 2025 via Zoom Final Agenda The meeting will take place via Zoom, a secure web conferencing tool. The meeting will run from 9:00am although this may be subject to change. Joining links and ...
Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...
Final guidance published today recommends lisocabtagene maraleucel (also called liso-cel or Breyanzi and made by Bristol Myers Squibb) as an option for treating people with large B-cell lymphoma when ...
This guideline has been updated and replaced by the NICE guideline on asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) [NG245] ...
This guideline covers rehabilitation after stroke for over 16s. It aims to ensure people are assessed for common problems and conditions linked to stroke, and get the care and therapy they need. It ...
Suggested remit: To appraise the clinical and cost effectiveness of vorasidenib within its marketing authorisation for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after ...
This guideline covers complex rehabilitation needs after traumatic injury, including assessment and goal setting, rehabilitation plans and programmes, physical, psychological and cognitive ...
Pegzilarginase for treating arginase-1 deficiency [ID4029]Home NICE Guidance Conditions and diseases Diabetes and other endocrinal, nutritional and metabolic conditions Metabolic conditions ...
1.2 FMT treatment is cheaper than almost all treatment options with antibiotics. It is not cost saving compared with vancomycin taper pulse if it's given using an enema. However, FMT via enema would ...
It is essential to provide reliable evidenced-based information on the benefits and risks of HRT to aid shared decision making between women, trans men and non-binary people registered female at birth ...